"And then on top of that, a key priority for us is to enable access in emerging markets, particularly Turkey, Brazil, but amongst other emerging markets as well, where there is significant SMA populations that could \u2013 children who could benefit from Zolgensma\u00ae. So we hope to see a steady pace of getting reimbursement decisions over the coming year."